Outsourcing Pharma
JULY 22, 2020
A leader from the specialty logistics firm discusses how the clinical researching industry is shifting, thanks in large part to the pandemic, and how to prepare for the future.
Drug Channels
JULY 24, 2020
Today’s guest post comes from Frank Dana, Chief Commercial Officer at ConnectiveRx. Frank discusses how the loss of commercial insurance coverage will affect the newly unemployed. He describes how ConnectiveRx's affordability tools can help pharmaceutical manufacturers and patients. To learn more, download ConnectiveRx’s free reference: Five Keys to Building a Successful Copay Strategy in the COVID-19 Era.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Mirror
JULY 23, 2020
DuPont Nutrition & Biosciences (DuPont) today announced a research collaboration in microbiome science with the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers University in New Jersey. The two-year research partnership will focus on improving the benefit/risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to potentially improve response rates through modulation.
Drug Patent Watch
JULY 24, 2020
The FDA Orange Book, or Approved Drug Products with Therapeutic Equivalence Evaluations, is the definitive source to link drugs with the patents that protect them. Over the years we’ve had…. The post Free Orange Book PDF Library from DrugPatentWatch appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
JULY 22, 2020
The company has expanded the footprint of the location to accommodate an anticipated increase in the need for COVID-19 vaccine and storage needs.
Drug Channels
JULY 23, 2020
The stunning growth of specialty pharmacies in the 340B Drug Pricing Program has accelerated a troubling trend: Patients covered by commercial insurance and Medicare Part D are footing the bill for 340B savings. That's the uncomfortable reality of the 340B program’s hidden prescription economics. Whenever a prescription is eligible for 340B pricing, an insured patient could pay thousands of dollars out of pocket—even as the 340B hospital and its contract pharmacy generate substantial profits
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Med Ed 101
JULY 19, 2020
Osteoporosis is the condition in which bone density is reduced and the patient has an increased risk of fractures. According to the International Osteoporosis Foundation, an estimated 44 million people in the US population aged 50 and older suffer from osteoporosis and low bone mass. There are many risk factors such as age, alteration of […]. The post Causes of Drug-Induced Osteoporosis appeared first on Med Ed 101.
Outsourcing Pharma
JULY 23, 2020
The CRO has been tapped by the Frederick National Laboratory for Cancer Research to provide clinical services for an ongoing COVID-19 study.
Drug Channels
JULY 21, 2020
Last week, I documented that nearly half of U.S. pharmacies now participate in the 340B Drug Pricing Program. Below, we update our exclusive analysis of the biggest specialty pharmacies within 340B. The four largest specialty pharmacies are owned by CVS Health, Cigna’s Express Scripts business, UnitedHealth Group’s OptumRx business, and Walgreens Boots Alliance/Prime Therapeutics.
Pharmacy Joe
JULY 19, 2020
In this episode, I’ll discuss why the new vancomycin guidelines made the switch to AUC/MIC based dosing. Episode 523: Why did the vancomycin guidelines make the switch to AUC/MIC based dosing? Subscribe on iTunes , Android , or Stitcher Shout out to “Pharmacy Hany” for inspiring this episode. A trough is only a single point estimate of drug exposure at the end of the dosing interval, while AUC/MIC refers to the area under the concentration curve in a 24 hour period divided by the min
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
NY Times
JULY 24, 2020
President Trump is trying to revive a 2016 campaign promise to control the rising price of medicines, but new executive orders are coming when he needs drugmakers to deliver coronavirus treatments.
Outsourcing Pharma
JULY 23, 2020
The US agency continues releasing resources, offering advice and taking actions related to the pandemic, and how life-sciences professionals respond.
Outsourcing Pharma
JULY 23, 2020
A leader from the genetic services company discusses how use of telemedicine can help pull in patients and keep trials going.
NY Times
JULY 24, 2020
President Trump on Friday signed a series of executive orders intended to lower the cost of prescription drugs in the United States.
Expert insights. Personalized for you.
126 
Let's personalize your content